235 related articles for article (PubMed ID: 19426754)
1. Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44.
Weber M; Chang WL; Durbin JP; Park PE; Luedtke RR; Mach RH; Swerdlow NR
Pharmacol Biochem Behav; 2009 Aug; 93(2):141-7. PubMed ID: 19426754
[TBL] [Abstract][Full Text] [Related]
2. Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.
Weber M; Chang WL; Breier M; Ko D; Swerdlow NR
Behav Pharmacol; 2008 Dec; 19(8):786-95. PubMed ID: 19020413
[TBL] [Abstract][Full Text] [Related]
3. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
[TBL] [Abstract][Full Text] [Related]
4. Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats.
Chang WL; Breier MR; Yang A; Swerdlow NR
Pharmacol Biochem Behav; 2011 Oct; 99(4):634-8. PubMed ID: 21683731
[TBL] [Abstract][Full Text] [Related]
5. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
Caine SB; Geyer MA; Swerdlow NR
Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
[TBL] [Abstract][Full Text] [Related]
6. Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effects.
Collins GT; Calinski DM; Newman AH; Grundt P; Woods JH
J Pharmacol Exp Ther; 2008 May; 325(2):691-7. PubMed ID: 18305018
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.
Gresack JE; Seymour PA; Schmidt CJ; Risbrough VB
Psychopharmacology (Berl); 2014 May; 231(10):2189-97. PubMed ID: 24363077
[TBL] [Abstract][Full Text] [Related]
9. Parametric approaches towards understanding the effects of the preferential D3 receptor agonist pramipexole on prepulse inhibition in rats.
Chang WL; Swerdlow NR; Breier MR; Thangaraj N; Weber M
Pharmacol Biochem Behav; 2010 Jun; 95(4):473-8. PubMed ID: 20385162
[TBL] [Abstract][Full Text] [Related]
10. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
[TBL] [Abstract][Full Text] [Related]
11. Proerectile effects of dopamine D2-like agonists are mediated by the D3 receptor in rats and mice.
Collins GT; Truccone A; Haji-Abdi F; Newman AH; Grundt P; Rice KC; Husbands SM; Greedy BM; Enguehard-Gueiffier C; Gueiffier A; Chen J; Wang S; Katz JL; Grandy DK; Sunahara RK; Woods JH
J Pharmacol Exp Ther; 2009 Apr; 329(1):210-7. PubMed ID: 19136638
[TBL] [Abstract][Full Text] [Related]
12. Dopamine agonist-induced hypothermia and disruption of prepulse inhibition: evidence for a role of D3 receptors?
Varty GB; Higgins GA
Behav Pharmacol; 1998 Sep; 9(5-6):445-55. PubMed ID: 9832930
[TBL] [Abstract][Full Text] [Related]
13. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A
Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
[TBL] [Abstract][Full Text] [Related]
14. Pramipexole effects on startle gating in rats and normal men.
Swerdlow NR; Lelham SA; Sutherland Owens AN; Chang WL; Sassen SD; Talledo JA
Psychopharmacology (Berl); 2009 Sep; 205(4):689-98. PubMed ID: 19506839
[TBL] [Abstract][Full Text] [Related]
15. The effects of the dopamine D2 agonist sumanirole on prepulse inhibition in rats.
Weber M; Chang WL; Breier MR; Yang A; Millan MJ; Swerdlow NR
Eur Neuropsychopharmacol; 2010 Jun; 20(6):421-5. PubMed ID: 20346635
[TBL] [Abstract][Full Text] [Related]
16. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.
Halberstadt AL; Geyer MA
Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
[TBL] [Abstract][Full Text] [Related]
18. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
[TBL] [Abstract][Full Text] [Related]
19. The discriminative stimulus effects of dopamine D2- and D3-preferring agonists in rats.
Koffarnus MN; Greedy B; Husbands SM; Grundt P; Newman AH; Woods JH
Psychopharmacology (Berl); 2009 Apr; 203(2):317-27. PubMed ID: 18807248
[TBL] [Abstract][Full Text] [Related]
20. Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies.
Qu Y; Swerdlow NR; Weber M; Stouffer D; Parsons LH
Pharmacol Biochem Behav; 2008 Oct; 90(4):686-90. PubMed ID: 18579193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
